Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AtheroGenics, Inc.{AGIX}-nasdaq -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (159)	11/21/2005 1:56:11 AM
From: tuck	Read Replies (1) \| Respond to of 332

>>It is not nice to call people freaks!<< The term "Biofreak" is an honorable one on the SI biotech boards. I don't know who coined it, perhaps Rick (if he didn't, he probably knows who did). For the individual so designated it might imply some level of biologic knowledge, but it certainly means he or she has a long-standing and passionate interest in the biotechnology sector. So you might just qualify. Anyhow, cool that you and I have independently come up with similar strategies for playing this one, apparently based on similar feelings about the outcome. It might be worth digging into AGIX' pipe; with the idea of going long if 1067 fails, and if the stock gets beaten below fair valuation of its assets and pipe. Best to have an idea of what that valuation is in advance. Cheers, Tuck